Evidence map›Paper›PMID 36671218›Full record

ReviewAntibiotics (Basel, Switzerland)2022

Pharmacokinetics of Antimicrobials in Children with Emphasis on Challenges Faced by Low and Middle Income Countries, a Clinical Review.

Kevin Meesters, Tinsae Alemayehu, Sofia Benou, Danilo Buonsenso, Eric H Decloedt, Veshni Pillay-Fuentes Lorente, Kevin J Downes, Karel Allegaert

Open access · goldAbstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. [Pharmacokinetic and metabolic considerations of antibiotic usage in children and the elderly].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Paediatric colistin prescribing practices in South Africa: A clinician survey.Southern African journal of infectious diseases · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 8 countries.

Kevin MeestersDepartment of Pediatrics, BC Children's Hospital and The University of British Columbia, 4500 Oak Street, Vancouver, BC V6H 3N1, Canada.ORCID 0000-0003-0666-3764
Tinsae AlemayehuDivision of Pediatric Infectious Diseases, Department of Pediatrics and Child Health, St. Paul's Hospital Millennium Medical College, Addis Ababa P.O. Box 1271, Ethiopia.
Sofia BenouDepartment of Pediatrics, General University Hospital of Patras, Medical School, University of Patras, 26504 Rion, Greece.
Danilo BuonsensoDepartment of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy.ORCID 0000-0001-8567-2639
Eric H DecloedtDivision of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7500, South Africa.ORCID 0000-0003-1815-5150
Veshni Pillay-Fuentes LorenteDivision of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7500, South Africa.ORCID 0000-0001-5365-0320
Kevin J DownesDepartment of Pediatrics, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Blvd, Philadelphia, PA 19104, USA.ORCID 0000-0001-5015-8146
Karel AllegaertDepartment of Development and Regeneration, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium.ORCID 0000-0001-9921-5105
Stellenbosch University · ZAChildren's Hospital of Philadelphia · USErasmus MC · NLSt. Paul's Hospital Millennium Medical College · ETUniversità Cattolica del Sacro Cuore · ITUniversity of British Columbia · CAUniversity of Patras · GR

Funding

Optimizing Vancomycin Therapy in ChildrenK23HD091365 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI DOWNES, KEVIN JAMES · 2018 to 2022
$747k
NICHD NIH HHS K23 HD091365
6 · The paper itself

Abstract

Effective antimicrobial exposure is essential to treat infections and prevent antimicrobial resistance, both being major public health problems in low and middle income countries (LMIC). Delivery of drug concentrations to the target site is governed by dose and pharmacokinetic processes (absorption, distribution, metabolism and excretion). However, specific data on the pharmacokinetics of antimicrobials in children living in LMIC settings are scarce. Additionally, there are significant logistical constraints to therapeutic drug monitoring that further emphasize the importance of understanding pharmacokinetics and dosing in LMIC. Both malnutrition and diarrheal disease reduce the extent of enteral absorption. Multiple antiretrovirals and antimycobacterial agents, commonly used by children in low resource settings, have potential interactions with other antimicrobials. Hypoalbuminemia, which may be the result of malnutrition, nephrotic syndrome or liver failure, increases the unbound concentrations of protein bound drugs that may therefore be eliminated faster. Kidney function develops rapidly during the first years of life and different inflammatory processes commonly augment renal clearance in febrile children, potentially resulting in subtherapeutic drug concentrations if doses are not adapted. Using a narrative review approach, we outline the effects of growth, maturation and comorbidities on maturational and disease specific effects on pharmacokinetics in children in LMIC.

Indexed as

antimicrobialschildrendevelopmental pharmacologypharmacokineticsPK/PD targets

Identifiers

PMID36671218
PMCPMC9854442
OpenAlexW4313414638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.